当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析 - 现金流量表

荣昌生物

(688331)

  

流通市值:216.96亿  总市值:750.92亿
流通股本:1.63亿   总股本:5.64亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,690,967,408.682,229,797,482.861,062,768,898.97475,062,495.73
  收到的税费返还3,199.683,199.683,199.681,051,545.22
  收到其他与经营活动有关的现金28,270,779.0126,135,188.3314,811,572.273,885,843.42
  经营活动现金流入小计2,719,241,387.372,255,935,870.871,077,583,670.92479,999,884.37
  购买商品、接受劳务支付的现金146,918,855.02104,074,192.6352,300,717.4613,281,935.21
  支付给职工以及为职工支付的现金1,022,486,815.72776,054,088.56531,384,544.56280,175,888.45
  支付的各项税费153,666,642.53106,451,519.8676,394,469.6441,460,861.06
  支付其他与经营活动有关的现金1,343,217,178.721,052,298,635.88663,043,194.53333,396,332.73
  经营活动现金流出小计2,666,289,491.992,038,878,436.931,323,122,926.19668,315,017.45
  经营活动产生的现金流量净额52,951,895.38217,057,433.94-245,539,255.27-188,315,133.08
二、投资活动产生的现金流量:
  收回投资收到的现金2,150,000,0001,050,000,000250,000,000150,000,000
  取得投资收益收到的现金3,250,378.421,606,295.09661,791.67177,625
  处置固定资产、无形资产和其他长期资产收回的现金净额2,130,338.941,610,219.631,414,066.7395,000
  收到的其他与投资活动有关的现金9,578,4009,578,4009,578,4009,578,400
  投资活动现金流入小计2,164,959,117.361,062,794,914.72261,654,258.4159,851,025
  购建固定资产、无形资产和其他长期资产支付的现金200,006,319.47175,212,674.86120,552,809.8135,638,909.83
  投资支付的现金2,170,600,694.881,167,127,956.2260,151,268.45151,000,000
  投资活动现金流出小计2,370,607,014.351,342,340,631.06380,704,078.26186,638,909.83
  投资活动产生的现金流量净额-205,647,896.99-279,545,716.34-119,049,819.86-26,787,884.83
三、筹资活动产生的现金流量:
  吸收投资收到的现金814,998,805.09783,623,475.65774,817,264.93232,945.36
  取得借款收到的现金2,034,726,064.981,333,647,815.421,198,221,840.57530,463,578.44
  收到其他与筹资活动有关的现金--1,836,362.93-
  筹资活动现金流入小计2,849,724,870.072,117,271,291.071,974,875,468.43530,696,523.8
  偿还债务支付的现金2,118,124,875.631,630,099,036.421,018,225,763.78316,006,600.73
  分配股利、利润或偿付利息支付的现金71,997,261.2566,397,042.9141,858,938.5723,994,702.42
  支付其他与筹资活动有关的现金107,644,447.9849,806,464.4134,454,700.6313,971,255.62
  筹资活动现金流出小计2,297,766,584.861,746,302,543.741,094,539,402.98353,972,558.77
  筹资活动产生的现金流量净额551,958,285.21370,968,747.33880,336,065.45176,723,965.03
四、汇率变动对现金及现金等价物的影响-4,193,799.09-620,373.83-4,276,762.99-2,367,997.43
五、现金及现金等价物净增加额395,068,484.51307,860,091.1511,470,227.33-40,747,050.31
  加:期初现金及现金等价物余额759,530,043.42759,530,043.42759,530,043.42759,530,043.42
  期末现金及现金等价物余额1,154,598,527.931,067,390,134.521,271,000,270.75718,782,993.11
补充资料:
  净利润709,649,797.14--449,568,663.07-
  资产减值准备1,953,331.57---
  固定资产和投资性房地产折旧249,580,354.82-125,411,013.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧249,580,354.82-125,411,013.43-
  无形资产摊销9,456,147.6-4,149,416.39-
  长期待摊费用摊销3,871,556.75-2,001,255.77-
  待摊费用的减少50,901.05---
  处置固定资产、无形资产和其他长期资产的损失771,569.73--178,554.91-
  固定资产报废损失139,048.99-48,950.98-
  公允价值变动损失-640,713,336.7--52,149.71-
  财务费用74,361,912.85-45,927,831.76-
  投资损失-4,235,581.12-4,433,931.62-
  存货的减少-720,374.08-18,121,441.28-
  经营性应收项目的减少-1,023,109,780.18-56,657,676.2-
  经营性应付项目的增加579,989,654.23--91,496,853.28-
  其他--12,139,512.52-
  现金的期末余额1,154,598,527.93-1,271,000,270.75-
  减:现金的期初余额759,530,043.42-759,530,043.42-
  现金及现金等价物的净增加额395,068,484.51-511,470,227.33-
公告日期2026-03-282025-10-312025-08-232025-04-29
审计意见(境内)标准无保留意见
TOP↑